AmierHaidar Profile Banner
Amier Haidar, MD, MPH Profile
Amier Haidar, MD, MPH

@AmierHaidar

Followers
1K
Following
1K
Media
11
Statuses
395

Cardiology Fellow @UTHealthHouston | IM @UCLAHealth | @McGovernMed '22 | MPH @UTHealthSPH | @UTAustin @TexasScience grad '18

Joined July 2013
Don't wanna be here? Send us removal request.
@gcfmd
Gregg Fonarow MD
16 hours
Do not be a 🦃 Rapidly initiate and optimize quadruple GDMT in all eligible patients with HFrEF ARNI+BB+MRA+SGLT2i ➡️ 7-11 extra years of Thanksgiving celebrations The time is now
1
16
36
@EricTopol
Eric Topol
13 days
We recently saw a randomized trial of exercise markedly improve cancer disease-free survival https://t.co/rJXBq11wmC. How can this be explained? https://t.co/F4QXCldUqV
14
251
817
@ACCinTouch
American College of Cardiology
1 month
@drbennisahmed
Ahmed Bennis MD 🫀
1 month
Adverse Pregnancy Outcomes and Long-Term Risk of Heart Failure in Women: National Cohort and Co-Sibling Study In this large national cohort, women who experienced any of 5 major adverse pregnancy outcomes had increased risk for HF up to 46 years later. Women with adverse
0
6
11
@ESC_Journals
European Society of Cardiology Journals
3 months
What is the cardiovascular risk of eleveated LDL cholesterol in the absence of coronary calcifications on computed tomography? Discover the results of the Western Denmark Heart Registry 👉 https://t.co/VX9QPXn5fw @RoccoMontone @ehj_ed #EHJ
1
57
186
@AmierHaidar
Amier Haidar, MD, MPH
5 months
Overlooked aspect of GLPs is the lean mass loss. We know the multitude of benefits muscle mass provides including CVD prevention. Weight training and counseling now more important than ever 🏋️
@TheLancetEndo
The Lancet Diabetes & Endocrinology
5 months
Online—Effects of #retatrutide on #body #composition in people with type 2 #diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial https://t.co/S7yKZtvcP7 #T2D #weightloss #leanmass
0
0
1
@AmierHaidar
Amier Haidar, MD, MPH
5 months
Cardiovascular risk associated with the use of cannabis and cannabinoids https://t.co/PrdadFxU2N
0
0
1
@ESC_Journals
European Society of Cardiology Journals
5 months
Temporal trends in CV risk factors among young acute #MI patients – is obesity becoming the worst villain? https://t.co/qJm4nhEi3k #EHJQCCO #CVD #@cpgale3 @diogoasantosfer @m_piepoli
2
31
83
@EricTopol
Eric Topol
6 months
Muscle mass loss in people aged 65+ taking GLP-1 drugs https://t.co/FB696cgkPA @AnnalsofIM Emphasis on resistance training (RET) and close monitoring recommended
7
60
270
@DOM_UCLA
Department of Medicine at UCLA Health
10 months
Shoutout to Dr. Amier Haidar for leading the UCLA Teen Heart Health Program, offering invaluable nutrition education to middle schoolers at the Neighborhood Youth Association in West LA. He’s helping build a foundation for a healthier, stronger community! https://t.co/2Jr4sep1xP
0
1
2
@gcfmd
Gregg Fonarow MD
7 months
National costs for CV related hospitalizations and procedures in 2021 Medicare: $39.7 Billion Medicaid: $8.3 Billion Private Insurance: $14.4 Billion @boback
1
2
7
@AmierHaidar
Amier Haidar, MD, MPH
7 months
New paper in @ESC_Journals @escardio @EJPCEiC Higher Fat mass, waist-to-height ratio, and waist circumference were each associated with increased risk for hard CHD events. Higher Fat Free Mass was associated with decreased risk for hard CHD events. https://t.co/uzhMvtCpki
Tweet card summary image
academic.oup.com
AbstractAims. Obesity, traditionally measured using body mass index (BMI), is considered a significant risk factor for the development of cardiovascular di
0
1
1
@AmierHaidar
Amier Haidar, MD, MPH
7 months
Examining the relationship between anthropometric and body composition measures with coronary heart disease events: the multi-ethnic study of atherosclerosis
Tweet card summary image
academic.oup.com
AbstractAims. Obesity, traditionally measured using body mass index (BMI), is considered a significant risk factor for the development of cardiovascular di
0
0
0
@ACCinTouch
American College of Cardiology
7 months
🗝️ Excessive body fat increases risk for chronic diseases like hypertension, diabetes, cancer. 🗝️ Obesity is a proinflammatory process leading to local and systemic inflammation. Learn how to reduce obesity-related cardiovascular risk: https://t.co/MlL247tyir #CardiologyMag
3
11
31
@AmierHaidar
Amier Haidar, MD, MPH
8 months
New in @ATHjournal individuals with both elevated Lp(a) and T2DM together have highest risk for CHD 🫀 Prioritize: Early detection 🤝 Focused prevention https://t.co/m5mGeuFxFM
0
2
7
@RishiRikhiMD
Rishi Rikhi, MD🌱MS
8 months
Published in @ATHjournal, we found a significant multiplicative interaction between Lp(a) and diabetes https://t.co/r6ijv0Wws6 @hsbhatia @Kazibwe_md @paragchevli @MonSangh @DrMichaelShapir @WFCardiology
4
13
33
@JAMACardio
JAMA Cardiology
10 months
Cardiovascular clinical trials in the US face low patient enrollment despite using many sites, highlighting a need for better trial infrastructure and recruitment strategies. https://t.co/uM5nfut2X9 @GCFMD @DLBhattMD @Mmack555 @javedbutler1
0
13
31
@pjhuffstutter
PJ Huffstutter
9 months
I've always found it both ironic (and jarring) that in parts of rural America - where much of the nation's food supply is grown or produced - that there are such high rates of food insecurity (meaning people struggled to provide enough food for their household members within the
3
4
7
@Farzad_MD
Farzad Mostashari
10 months
16/ When you hear, "the CDC's Epidemic Intelligence Service class was cancelled and the officers fired" I hope this gives you a sense of what has been lost. Not just the outbreaks that can't be investigated, the surge capacity gone, but our future public health leadership lost
326
2K
10K
@AmierHaidar
Amier Haidar, MD, MPH
11 months
Health Care Costs for Cardiovascular-Related Care High and Trending Upwards in the US
Tweet card summary image
thecardiologyadvisor.com
Costs related to cardiovascular health care represent a high burden and have been trending upward the past several years in the United States.
0
0
1
@DrKarlNadolsky
Karl Nadolsky
1 year
The people who sell worthless, unregulated supplements are the ones arguing against use of prescription meds with proven benefits and safety 🧐
13
28
169